FDA Approves First New Sunscreen Ingredient in 20 Years

For the first time in over 20 years, Americans are getting access to a new sunscreen ingredient that dermatologists say could save lives.

The FDA announced today that bemotrizinol has been approved for use in US sunscreens. This chemical filter has protected European skin for decades, and now it's finally our turn to benefit from its superior protection.

The approval is a huge deal because American sunscreen has lagged behind the rest of the world for years. Until now, only two ingredients held the FDA's gold standard safety rating: zinc oxide and titanium dioxide. Many popular chemical filters remain under safety review, leaving their long-term effects uncertain.

Bemotrizinol changes the game in three major ways. First, it blocks long-wave UVA rays better than current options, targeting the wavelength that penetrates deepest and causes the most skin cancers. Second, it doesn't break down quickly in sunlight, meaning better protection without constant reapplication. Third, it's gentle enough for even the most sensitive skin.

"We have been stuck in the past, while the rest of the world enjoys superior formulas with lightweight, elegant, safer sunscreens with better protection," says Dr. Gary Goldenberg, a board-certified dermatologist in New York City. He calls the approval "excellent news and long overdue."

The ingredient also plays nicely with other sunscreen components, providing higher SPF protection at lower doses. This means lighter formulas that don't feel heavy or greasy on skin.

Why This Inspires

Dr. Joshua Zeichner, director of cosmetic and clinical research at Mount Sinai Hospital, captures what this approval really means. "Another sunscreen ingredient will give people better tools to protect against the sun's harmful rays," he explains. "Ultimately this will mean fewer skin cancers, including melanomas, which are potentially fatal."

For people with sensitive skin who struggle to find sunscreen that doesn't irritate, this approval opens new doors. Dr. Ife Rodney, a dermatologist and founding director of Eternal Dermatology Aesthetics, says bemotrizinol offers hope for those who've had limited options.

Sunscreen manufacturers have been anticipating this approval and may already be testing formulas. While products won't hit shelves immediately, the wait is finally over for American sunscreen innovation.

Dr. Zeichner isn't hiding his excitement: "As soon as sunscreens in the US begin to be produced with bemotrizinol, I can tell you that I will be the first in line to purchase it."